Sort
48,018 grants matching “immunotherapy”
Amyloid Beta CAR Macrophages: a cell engineering strategy to clear pathogenic proteins
$710,765Saar Gill · University Of Pennsylvania · R01 · FY2023 · NS
Defining correlates of protection from dengue illness in a long-term cohort study of multigenerational house-holds in Thailand
$710,711Kathryn B Anderson · Upstate Medical University · R01 · FY2023 · AI
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$710,483Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Micro-nanotechnologies for the analysis of islet-derived extracellular vesicles implicated in Type 1 Diabetes
$710,385Alphonsus Ng · University Of Utah · R01 · FY2024 · DK
IMMUNOTHERAPY OF PROSTATE CANCER WITH GENETICALLY ENHANCES TUMOR-SPECIFIC T-CELL PRECURSORS
$710,378Sloan-Kettering Institute For Cancer Research · · FY2009 · Department of the Army
A spatial profiling-based immune hub perturbation platform to improve immunotherapy in colon cancer
$710,361Karin Pelka · J. David Gladstone Institutes · R37 · FY2025 · CA
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
$710,220Robert H Gilman · Johns Hopkins University · R01 · FY2021 · AI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
$710,207Robert H Gilman · Johns Hopkins University · R01 · FY2020 · AI
Preclinical development and clinical monitoring of adoptive immune therapy
$710,207Francis Flomerfelt · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Interrogating Mechanisms of Anti-tumor Immunity in Human Subjects and Murine Models of IDH-Mutant Glioma Treated with All-Trans Retinoic Acid and PD-1 Inhibition
$710,142Nduka Mgbechinyere Amankulor · University Of Pennsylvania · R37 · FY2025 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer livermetastasis
$710,138Wendy S. Garrett · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · CA
Quantitative Endogenous MRI Imaging of Neuroinflammation in AD
$710,056Qing Wang · Washington University · R01 · FY2025 · AG
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptors
$710,049Frederick Albert Matsen · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Antibodies, B cells and resistance to human cryptococcosis
$709,959Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Unraveling the cell divergent roles of Glucocorticoid-Induced TNF-R Related Protein (GITR): A new opportunity to treat atherosclerosis using targeted immunotherapy
$709,869Esther Lutgens · Mayo Clinic Rochester · R01 · FY2025 · HL
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
$709,775Harriet M Kluger · Yale University · K12 · FY2022 · CA
Project 3: Hyperimmune globulin prophylaxis and treatment of ZIKV in pregnancy
$709,685David H Oconnor · University Of Wisconsin-Madison · P01 · FY2019 · AI
Neoadjuvant SEMA4D/ICB therapy for melanoma
$709,554Chrystal Mary Paulos · Emory University · R01 · FY2025 · CA
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy
$709,419Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Biology and genetics of metastatic disease
$709,351Sohail F. Tavazoie · Rockefeller University · R35 · FY2022 · CA
Yale SPORE in Skin Cancer
$709,079Ruth Halaban · Yale University · P50 · FY2017 · CA
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
$708,822Dean W Felsher · Stanford University · R01 · FY2019 · CA
ENHANCING T-CELL IMMUNOTHERAPY TO TREAT PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS
$708,546Children'S Research Institute · · FY2021 · Defense Health Agency
Mechanisms of CTL Resistance in HIV Reservoirs
$708,526R. Brad Jones · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Mechanisms of CTL Resistance in HIV Reservoirs
$708,526R. Brad Jones · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI